David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Health Care Analysis 20 (1):50-65 (2012)
In the US, stem cell research is at a moral impasse—many see this research as ethically mandated due to its potential for ameliorating major diseases, while others see this research as ethically impermissible because it typically involves the destruction of embryos and use of ova from women. Because their creation does not require embryos or ova, induced pluripotent stem cells offer the most promising path for addressing the main ethical objections to stem cell research; however, this technology is still in development. In order for scientists to advance induced pluripotent stem cell research to a point of translational readiness, they must continue to use ova and embryos in the interim. How then are we to ethically move forward with stem cell research? We argue that there is personal integrity and value in adopting a ‘moral compromise’ as a means for moving past the moral impasse in stem cell research. In a moral compromise, each party concedes part of their desired outcome in order to engage in a process that respects the values and desires of all parties equitably. Whereas some contend that moral compromise in stem cell research necessarily involves self-contradiction or loss of personal integrity, we argue that in the US context, stem cell research satisfies many of the key pre-conditions of an effective moral compromise. To illustrate our point, we offer a model solution wherein eggs and embryos are temporarily used until non-egg and non-embryonic sources of pluripotent stem cells are developed to a state of translational readiness.
|Keywords||Moral compromise Stem cell research Stem cell policy Embryo Moral status Women’s health|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Glenn McGee & Arthur L. Caplan (1999). The Ethics and Politics of Small Sacrifices in Stem Cell Research. Kennedy Institute of Ethics Journal 9 (2):151-158.
Nikolaus Knoepffler (2004). Stem Cell Research: An Ethical Evaluation of Policy Options. Kennedy Institute of Ethics Journal 14 (1):55-74.
John A. Robertson (1999). Ethics and Policy in Embryonic Stem Cell Research. Kennedy Institute of Ethics Journal 9 (2):109-136.
Bernard Dickens, International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006).
David A. Jensen (2008). Abortion, Embryonic Stem Cell Research, and Waste. Theoretical Medicine and Bioethics 29 (1):27-41.
Tamra Lysaght & Alastair V. Campbell (2013). Broadening the Scope of Debates Around Stem Cell Research. Bioethics 27 (5):251-256.
Elizabeth Harman (2007). How is the Ethics of Stem Cell Research Different From the Ethics of Abortion? Metaphilosophy 38 (2-3):207–225.
Howard J. Curzer (2004). The Ethics of Embryonic Stem Cell Research. Journal of Medicine and Philosophy 29 (5):533 – 562.
Richard M. Doerflinger (1999). The Ethics of Funding Embryonic Stem Cell Research: A Catholic Viewpoint. Kennedy Institute of Ethics Journal 9 (2):137-150.
Hossam E. Fadel (2012). Developments in Stem Cell Research and Therapeutic Cloning: Islamic Ethical Positions, a Review. Bioethics 26 (3):128-135.
Katrien Devolder & John Harris (2005). Compromise and Moral Complicity in the Embryonic Stem Cell Debate. In Nafsika Athanassoulis (ed.), Philosophical Reflections on Medical Ethics. Palgrave Macmillan.
O. Carter Snead (2012). The Law and Politics of Embryo Research in America. Human Reproduction and Genetic Ethics 17 (1):40-52.
David Magnus (2010). Translating Stem Cell Research: Challenges at the Research Frontier. Journal of Law, Medicine and Ethics 38 (2):267-276.
Added to index2012-02-11
Total downloads10 ( #118,255 of 1,004,645 )
Recent downloads (6 months)1 ( #64,617 of 1,004,645 )
How can I increase my downloads?